tradingkey.logo
Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo

LakeShore Biopharma Co Ltd

LSB

0.740USD

+0.003+0.39%
Market hours （ET）Quotes delayed by 15 min
14.12MMarket Cap
--P/E TTM

LakeShore Biopharma Co Ltd

0.740

+0.003+0.39%
OverviewCompanyFinancials
Statements
Income Statement
Balance Sheet
Cash Flow Statement

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025H1
FY2024H2
FY2024H1
Total revenue
36.20%371.94M
--300.33M
--273.09M
Revenue
36.20%371.94M
--300.33M
--273.09M
Cost of revenue
23.94%64.68M
--65.50M
--52.19M
Operating expenses
-25.26%341.08M
--405.48M
--456.35M
R&D expenses
-61.71%68.49M
--123.95M
--178.85M
Depreciation, depletion, and amortization
27.49%25.41M
--22.25M
--19.93M
Operating profit
116.84%30.86M
---105.16M
---183.26M
Net non-operating interest income (expenses)
Non-operating interest income
----
----
--1.96M
Non-operating interest expense
-55.96%6.57M
----
--14.93M
Gains from sale of securities
----
---44.34M
----
Special income (expenses)
-95.40%315.00K
---159.81M
--6.85M
- Gains from disposal of fixed assets
---8.21M
----
----
Other non-operating income (expenses)
-61.47%5.41M
--16.49M
--14.03M
Income before tax
112.43%21.80M
---279.85M
---175.34M
Income tax
248.47%1.22M
---20.91M
---820.35K
Income after tax
111.79%20.58M
---258.94M
---174.52M
Net income from continuous operations
111.79%20.58M
---258.94M
---174.52M
Net income attributable to controlling interests
111.79%20.58M
---258.94M
---174.52M
Preferred share dividend
----
--0.00
----
Net income attributable to common shareholders
111.79%20.58M
---258.94M
---174.52M
Basic earnings per share
105.76%1.08
---21.44
---18.75
Diluted earnings per share
105.76%1.08
---21.44
---18.75
Dividend per share
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
Audit opinions
--
--
--
KeyAI